Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation

Mayo Clinic

Status: Completed

Conditions: Infection; Cytomegalovirus Infections; Transplantation

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00170170

2275-04

VAL101

Details and patient eligibility

About

This study will investigate the clinical variables that may be used to predict who among the solid organ transplant recipients will develop cytomegalovirus (CMV) disease after completing antiviral prophylaxis.

Full description

This study will investigate the clinical and laboratory variables that may be used to predict who among the solid organ transplant recipients will develop CMV disease after completing antiviral prophylaxis. This is a retrospective study of patients seen at the Mayo Clinic during the past five years.

Enrollment: 500 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Recipients of liver, kidney, pancreas, heart or lung transplantation